← Leaderboards
Christopher Baum
Children'S Hospital Med Ctr (Cincinnati)
$917,017
Attributed
$917,017
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $236.2K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$917,017 · 1
By mechanism
R01$917,017 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Nancy M. Sawtell$5,678,947
- Christof Von Kalle$1,461,943
- Douglas W Houston$6,828,218
- Gregory M Tiao$5,042,111
- Jun Ma$2,466,410
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsActivation, GeneArchitectureArtsAlpha-ThalassemiaBiologicalBone Marrow TransplantationCell LineCellsClassificationBaseClinically RelevantClone CellsCombinatorialCommunitiesConditionDesignDoseEventFrequencies (Time Pattern)FutureGenealogyClinical EfficacyGenes
Grant awards (4)
Prevention of insertional mutagenesis in gene therapy$224,720
R01 · FY2008 · CA · contact PI
Prevention of insertional mutagenesis in gene therapy$224,720
R01 · FY2007 · CA · contact PI
Prevention of insertional mutagenesis in gene therapy$231,367
R01 · FY2006 · CA · contact PI
Prevention of insertional mutagenesis in gene therapy$236,210
R01 · FY2005 · CA